KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Return on Equity (2016 - 2025)

Historic Return on Equity for Eli Lilly (LLY) over the last 16 years, with Q3 2025 value amounting to 0.87%.

  • Eli Lilly's Return on Equity rose 2700.0% to 0.87% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.87%, marking a year-over-year increase of 2700.0%. This contributed to the annual value of 0.84% for FY2024, which is 3600.0% up from last year.
  • Eli Lilly's Return on Equity amounted to 0.87% in Q3 2025, which was up 2700.0% from 0.81% recorded in Q2 2025.
  • In the past 5 years, Eli Lilly's Return on Equity ranged from a high of 0.87% in Q3 2025 and a low of 0.21% during Q1 2021
  • Moreover, its 5-year median value for Return on Equity was 0.6% (2022), whereas its average is 0.59%.
  • Its Return on Equity has fluctuated over the past 5 years, first soared by 4500bps in 2022, then crashed by -2000bps in 2023.
  • Over the past 5 years, Eli Lilly's Return on Equity (Quarter) stood at 0.65% in 2021, then decreased by -9bps to 0.6% in 2022, then decreased by -21bps to 0.47% in 2023, then surged by 57bps to 0.74% in 2024, then grew by 18bps to 0.87% in 2025.
  • Its last three reported values are 0.87% in Q3 2025, 0.81% for Q2 2025, and 0.74% during Q1 2025.